To include your compound in the COVID-19 Resource Center, submit it here.

Seliciclib: Phase I data

A Phase I trial showed that 7 of 14 evaluable patients had clinical evidence of

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE